[144] Alpha Tau Medical Ltd. SEC Filing

Rhea-AI Filing Summary

Alpha Tau Medical Ltd. filing: a Form 144 notice reports a proposed sale of 32,500 ordinary shares through Oppenheimer & Co. Inc. on NASDAQ. The excerpt also records shares issued upon RSU vesting: 21,722 shares on 03/21/2022 and 71,988 shares on 03/07/2024. The filing lists the broker-dealer and a date of 06/03/2026 alongside the share quantity.

Insights

Securities Compliance Lawyer

Form 144 reports a proposed broker-mediated resale of registered shares.

Form 144 is a regulatory notice used when selling restricted or control securities; this excerpt shows a broker-dealer (Oppenheimer & Co.) and a listed quantity of 32,500 ordinary shares. The filing also documents prior RSU vesting events on 03/21/2022 and 03/07/2024.

Timing, lock-up or resale conditions are not provided in the excerpt; subsequent regulatory or broker confirmations would specify execution timing and settlement details.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	32500	290225.00	88009737	06/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	03/21/2022	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			21722	03/21/2022	No consideration, shares issued upon vesting of RSUs
Ordinary Shares	03/07/2024	Shares issued upon vesting of RSUs	Alpha Tau Medical Ltd.			71988	03/07/2024	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)